RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of “Hold” from Analysts

RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned a consensus rating of “Hold” from the twelve analysts that are covering the stock, Marketbeat reports. Nine equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among analysts […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set Sleep Country Canada Holdings Inc. (TSE:ZZZ) Target Price at C$33.79
Next post Brokerages Set VIZIO Holding Corp. (NYSE:VZIO) Target Price at $10.77